Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Comparing oral NSAI to acetaminophen or placebo for treating renal colic after emergency discharge

Official title: The Investigation of the Efficacity and Safety of Oral Non Steroidal Anti Inflammatory (NSAI) Drugs Such as Piroxicam as a Second Line Treatment of Patients Consulting the Emergency Department for Renal Colics

Run by University of Monastir · NCT05722782 · Data updated 2026-11-12

This study is testing whether a pain medication called piroxicam works better than acetaminophen or a placebo for adults who have been treated for kidney stone pain in the emergency room.

More Renal Colic trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorUniversity of Monastir
Academic / other
Locations1 site (Monastir)
StatusRecruiting
StartedJuly 1, 2023
Main results expectedJune 2027
Study endsDecember 2027
Registry record updatedNovember 14, 2023
Trial IDNCT05722782 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who have been treated for renal colic in the emergency department and can consent to participate.

Probably not a fit

Patients with contraindications to NSAI or acetaminophen treatment will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of oral non-steroidal anti-inflammatory drugs (NSAI), specifically piroxicam, in treating patients discharged from the emergency department after experiencing renal colic. The research aims to assess the recurrence of pain, reconsultation rates, and hospital admissions among patients receiving piroxicam compared to those receiving acetaminophen or a placebo. By focusing on a common yet under-researched condition, the study seeks to provide clearer recommendations for outpatient treatment of renal colic. The study will include adult patients who have been treated for renal colic in the emergency department and consent to participate.

Why it matters

Potential benefit: If successful, this study could provide a more effective outpatient treatment option for patients suffering from renal colic.

How similar studies have gone: While there is limited research specifically on oral NSAI for renal colic, similar studies have explored NSAI use in pain management, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 18 years old
* Consenting to participate in the study
* Patients treated in the ED for RC
* No contraindications of NSAI or paracetamol treatment

Exclusion Criteria:

* Contraindication of NSAI treatment
* Patients non reachable by telephone call
* Patients that did not receive or use the treatment

Where it's running

  • Fattouma Bourguiba University Hospital
    Monastir, Tunisia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.